BetterScholar BetterScholar
12
Role
Title
Level Year L/R
🐢 Frequent EpCam protein expression in human carcinomas.
7 auth. P. Went, A. Lugli, S. Meier, M. Bundi, M. Mirlacher, G. Sauter, ... S. Dirnhofer
9 2004
9
🐢
🐜 Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice.
7 auth. R. Tiedt, Hao Hui, M. Sobas, R. Looser, S. Dirnhofer, J. Schwaller, ... R. Skoda
8 2007
8
🐜
🐢 Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin’s lymphoma
A. Tzankov, Cecile Meier, Petra Hirschmann, P. Went, S. Pileri, S. Dirnhofer
8 2008
8
🐢
🐜 Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells
10 auth. E. Gunsilius, H. Duba, A. Petzer, C. M. Kahler, K. Grunewald, G. Stockhammer, ... C. Gabl, S. Dirnhofer, J. Clausen, G. Gastl
8 2000
8
🐜
🐜 Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study
36 auth. Carlo Visco, A. Tzankov, Z. Xu-Monette, Roberto N. Miranda, Yu Chuan Tai, Yan Li, Wei-min Liu, E. d'Amore, Yong Li, S. Montes-Moreno, K. Dybkær, April Chiu, A. Orazi, Y. Zu, Govind Bhagat, ... Huan-You Wang, Cherie H. Dunphy, Eric D. His, X. F. Zhao, W. Choi, Xiaoying Zhao, J. H. van Krieken, Qin Huang, Weiyun Ai, Stacey O'Neill, M. Ponzoni, A. Ferreri, Brad S. Kahl, Jane N Winter, Ronald S. Go, S. Dirnhofer, Miguel A. Piris, M. Møller, Lin Wu, L. J. Medeiros, Ken H Young
8 2013
8
🐜
🐜 Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor).
15 auth. M. Heinrich, G. McArthur, G. Demetri, H. Joensuu, P. Bono, R. Herrmann, H. Hirte, S. Cresta, D. B. Koslin, C. Corless, ... S. Dirnhofer, A. V. van Oosterom, Z. Nikolova, S. Dimitrijević, J. Fletcher
8 2006
8
🐜
🐜 T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17
8 auth. Manu Rangachari, N. Mauermann, René R. Marty, S. Dirnhofer, M. Kurrer, Vukoslav Komnenovic, ... J. Penninger, U. Eriksson
8 2006
8
🐜
🐜 Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion
27 auth. Anna M. Paczulla, Kathrin Rothfelder, S. Raffel, M. Konantz, Julia Steinbacher, Hui Wang, Claudia Tandler, M. Mbarga, T. Schaefer, M. Falcone, E. Nievergall, D. Dörfel, Pauline Hanns, J. Passweg, C. Lutz, ... J. Schwaller, R. Zeiser, B. Blazar, M. Caligiuri, S. Dirnhofer, P. Lundberg, L. Kanz, L. Quintanilla‐Martinez, A. Steinle, A. Trumpp, H. Salih, C. Lengerke
8 2019
8
🐜
🐬 Life with a Single Isoform of Akt: Mice Lacking Akt2 and Akt3 Are Viable but Display Impaired Glucose Homeostasis and Growth Deficiencies
Bettina A. Dummler, O. Tschopp, Debby Hynx, Zhong-Zhou Yang, S. Dirnhofer, B. Hemmings
8 2006
8
🐬
🐜 PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma
17 auth. Matthias Pfeifer, M. Grau, D. Lenze, Sören-Sebastian Wenzel, Annette Wolf, B. Wollert-Wulf, K. Dietze, H. Nogai, B. Storek, H. Madle, ... B. Dörken, M. Janz, S. Dirnhofer, P. Lenz, M. Hummel, A. Tzankov, G. Lenz
8 2013
8
🐜
🐜 High Ep-CAM Expression is Associated with Poor Prognosis in Node-positive Breast Cancer
20 auth. G. Spizzo, G. Gastl, P. Obrist, P. Went, S. Dirnhofer, S. Bischoff, M. Mirlacher, G. Sauter, R. Simon, Shanna Stopatschinskaya, ... Philippe Haas, R. Bart, O. Köchli, H. Spichtin, R. Maurer, U. Metzger, B. von Castelberg, M. Zuber, Friedrich Mross, H. Dietrich
7 2004
7
🐜
🐜 Akt/PKB-mediated phosphorylation of Twist1 promotes tumor metastasis via mediating cross-talk between PI3K/Akt and TGF-β signaling axes.
8 auth. G. Xue, D. Restuccia, Q. Lan, Debby Hynx, S. Dirnhofer, D. Hess, ... C. Rüegg, B. Hemmings
7 2012
7
🐜